GlassScriptPhysician profile
Ihor Pidhorecky
NPI 1689660367
$21,137.71
in general payments reported to CMS, 2019-2025
26 companies · $545 in 2025
The $545 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $7,285 · 2021: $12K · 2022: $725 · 2023: $239 · 2024: $280 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $19,226.54 | 2019-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $293.23 | 2021-2024 | Dermabond Prineo |
| Innovation Technologies INC | $188.15 | 2024 | Irrisept |
| Endomagnetics LTD | $173.60 | 2022-2023 | Magtrace, Magseed |
| Hologic Sales and Service, LLC | $147.11 | 2023-2025 | Magseed, Coolseal Generator |
| Solventum Corporation | $133.91 | 2025 | V.A.C. Veraflo Cleanse Choice, Abthera Advance |
| Advanced Accelerator Applications | $128.55 | 2020 | |
| Stryker Corporation | $126.12 | 2025 | Molli |
| Biotissue Holdings INC. | $95.23 | 2022 | |
| Conmed Corporation | $78.65 | 2021 | |
| Myriad Genetic Laboratories, INC. | $75.91 | 2021-2025 | Myrisk |
| Celgene Corporation | $74.87 | 2019 | |
| Lexington Medical, INC. | $73.73 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Tela Bio, INC. | $47.37 | 2024 | Ovitex 2s |
| Kerecis Limited | $41.23 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $37.00 | 2023 | |
| Leica Microsystems INC. | $30.89 | 2021 | |
| Dilon Technologies, INC. | $25.33 | 2023 | Hemoblast Bellows |
| Cook Medical LLC | $24.00 | 2019 | |
| Ge Healthcare | $23.97 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $17.48 | 2022 | |
| Acera Surgical, INC. | $16.60 | 2025 | Restrata Wound Matrix |
| Medtronic, INC. | $16.42 | 2025 | Ligasure |
| Csl Behring | $16.25 | 2021 | |
| Kci USA, INC. | $14.93 | 2019 | |
| Acell, INC. | $10.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ihor Pidhorecky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.